Related Experiment Video
Updated: May 8, 2026

Identification of Kinesin-1 Cargos Using Fluorescence Microscopy
Published on: February 14, 2016
Kinesins and cancer
1The Beatson Institute for Cancer Research, Garscube Estate, Switchback Road, Bearsden, Glasgow G61 1BD, Scotland, UK.
Abstract:
Kinesins are a family of molecular motors that travel unidirectionally along microtubule tracks to fulfil their many roles in intracellular transport or cell division. Over the past few years kinesins that are involved in mitosis have emerged as potential targets for cancer drug development. Several compounds that inhibit two mitotic kinesins (EG5 (also known as KIF11) and centromere-associated protein E (CENPE)) have entered Phase I and II clinical trials either as monotherapies or in combination with other drugs. Additional mitotic kinesins are currently being validated as drug targets, raising the possibility that the range of kinesin-based drug targets may expand in the future.
Insights
Mitotic kinesins, crucial for cell division, are emerging as promising cancer drug targets. Inhibitors for kinesin Eg5 (KIF11) and CENPE are in clinical trials, with more targets under investigation.
Area of Science:
- Molecular biology
- Cell biology
- Pharmacology
Background:
- Kinesins are microtubule-based motor proteins essential for intracellular transport and cell division.
- Mitotic kinesins play critical roles during cell division (mitosis).
Purpose of the Study:
- To highlight the potential of mitotic kinesins as targets for cancer drug development.
- To review the progress of kinesin-based cancer therapeutics currently in clinical trials.
Main Methods:
- Review of current research and clinical trial data on mitotic kinesin inhibitors.
- Identification and validation of novel mitotic kinesin targets for drug development.
Main Results:
- Compounds inhibiting Eg5 (KIF11) and CENPE have advanced to Phase I and II clinical trials.
- These inhibitors are being tested as monotherapies and in combination treatments.
- Several additional mitotic kinesins are undergoing validation as potential drug targets.
Conclusions:
- Mitotic kinesins represent a promising class of targets for novel cancer therapies.
- The pipeline for kinesin-based cancer drugs is expanding, with potential for future therapeutic advancements.
Related Concept Videos
Destabilization of Microtubules
Microtubule Associated Motor Proteins
The Movement of Organelles and Vesicles
Anaphase A and B
Plus-end depolymerization releases tubulin heterodimers from the terminal region of the microtubule. As tubulin subunits are lost, the Ndc80 complexes detach...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Cancer Cell Migration through Invadopodia

